
Results showed that the ingredient significantly decreased intraocular pressure, increased tear break-up time and volume, and decreased corneal inflammation, leading to the stabilization of the rats’ ocular surface.

Results showed that the ingredient significantly decreased intraocular pressure, increased tear break-up time and volume, and decreased corneal inflammation, leading to the stabilization of the rats’ ocular surface.

Study finds that boosting omega-3 levels at early midlife may offer the best results for reducing the risk of age-related cognitive decline long-term.

Subjects showed improvements in hand grip strength tests as well as thinking, learning, memory, and concentration parameters of the psychological function domain of quality of life survey.

According to the organization, laboratories quantifying fatty acid content may not know how to properly set up instruments to achieve accurate results.

Natural Remedies launched Holixer holy basil/tulsi, an adaptogen that studies has shown inhibits and/or reduces cortisol release from the adrenal glands in response to stress-induced production of adrenocorticotropic hormone.

Results showed that at doses, ranging from 3 grams to 20 grams per day, the abundance of Bifidobacterium significantly increased.

The new ADM Science and Technology Center is officially open at the University of Illinois Research Park.

The patent demonstrates the synergistic effects of thymoquinone and omega-3 fatty acids for healthy inflammatory responses.

Vedic Lifesciences, a contract research organization based, has completed a randomized, controlled dose response study for Interpath Pty Ltd. on its patented ingredient called Epiitalis.

The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has issued a statement acknowledging the relationship between omega-3 EPA and DHA blood levels and preterm birth risk.

Ingredion Inc. shared the results of its global environmental lifecycle assessment of stevia as compared to full-caloric options, such as cane sugar, using environmental indicators including climate change, land use, water scarcity, and cumulative energy demand.

Advances in infant foods, formulas, and supplements yield products to meet numerous infant health needs.

An initiative of the MetaGenoPolis unit of INRAE (the National Research Institute for Agriculture, Food and the Environment), the French Gut Project is a research project that has set out to collect 100,000 French intestinal metagenomes for analysis

InVivo Biosciences and Thaena Inc. have announced results from recent research demonstrating measurably superior healthspan and lifespan benefits of ThaenaBiotic powder, a sterilized postbiotic mixture derived from healthy human stool.

Results showed that supplementation with the cocoa extract did not have a significant effect on global cognition, but relative to placebo, multivitamin mineral supplementation did provide significant benefit for global cognition.

Results showed that, compared to placebo, subjects taking the microalgae supplement had fewer upper respiratory tract complaints, better overall well-being, as well as lower cortisol and superior microbiome indices.

An influx of next-generation ingredients and a growing consumer need are driving joint health supplements to new heights.

The study aims to determine the safety and effectiveness of the ingredient on improving long- and short-term memory, concentration, and clarity of thinking in healthy individuals. The study is planned for completion in November.

The extract helped improve lameness scores and inflammatory biomarkers in horses.

Clinical trials design best practices for nutraceuticals

The studies did not find a reduction in COVID-19 incidence after vitamin D supplementation, but a successful vaccination rollout may have impacted the results of the study.

The average time to achieve maximum levels in plasma following supplementation with the sustained release tablet was about 4.5 hours compared to the two to three hours seen in immediate-release formulations.

The study found that subjects with mild to moderate seborrhea of the scalp saw a significant 58.8.% reduction in erythema scores and a substantial 30% decrease in scaling scores after 28 days of using a 5% B’utyQuin Scalp Serum.

Dubbed the VETA Trial (Vitamin D, K2 plus Empagliflozin combination in Type Two Diabetes Mellitus), the six-month prospective, randomized, controlled, open-label, multicenter trial will be conducted in collaboration with the University of Health Sciences Lahore (Pakistan) and the Pakistan Society of Internal Medicine.

Stiriti Ingredients LLC has announced its official entry into the North American dietary supplement, function food and beverage market with its signature SA3X Spilanthes acmella ingredient.